Manuka Honey in Second- and Grafted Third-degree Burns
Clinical Application Observation of Manuka Honey in Second- and Grafted Third-degree Burns
1 other identifier
interventional
10
1 country
2
Brief Summary
Treatment strategies of II. degree burn wounds and split-skin grafted III. degree burn wounds aim at reducing infection and improving reepithelialization. The aim of this study is to evaluate time to reepithelialization, pain, microbiology and handling of manuka honey dressings with second-degree burn wounds and split-skin grafted burn wounds.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2015
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 15, 2015
CompletedFirst Submitted
Initial submission to the registry
January 28, 2017
CompletedFirst Posted
Study publicly available on registry
February 9, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2023
CompletedFebruary 24, 2023
February 1, 2023
8.4 years
January 28, 2017
February 22, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Epithelialization
Rate of Epithelialization in percent
Up to 1 year
Secondary Outcomes (3)
Pain
Up to 1 year
Microbiology
Up to 1 year
Handling
Up to 1 year
Study Arms (1)
Burn with or without split-skin graft
EXPERIMENTALSecond degree burns and third degree burns with split-skin graft that need wound dressings
Interventions
Eligibility Criteria
You may qualify if:
- Consent-capable male and female patients (or guardian)
- ≥18 years of age
- ability to asses pain
You may not qualify if:
- Immunosuppressive Therapy
- Clinical wound infection
- Allergy against honey
- Relationship to someone who is involved in the study design or assessment
- Participation in other clinical trials
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital Schleswig-Holsteinlead
- University of Luebeckcollaborator
Study Sites (2)
University Hospital Schleswig-Holstein
Lübeck, Schleswig-Holstein, 23538, Germany
University of Schleswig-Holstein
Lübeck, Schleswig-Holstein, 23538, Germany
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tobias Kisch, MD
University of Lübeck, University Hospital Schleswig-Holstein
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
January 28, 2017
First Posted
February 9, 2017
Study Start
July 15, 2015
Primary Completion
December 1, 2023
Study Completion
December 1, 2023
Last Updated
February 24, 2023
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will not share